Dr. Lou Ann Mitchell, M.D Family Medicine Medicare: Medicare Enrolled Practice Location: 1646 305th St, Tama, IA 52339 Phone: 641-484-4094 Fax: 641-484-2432 |
Jerry Wille, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 402 Siegel St, Tama, IA 52339 Phone: 641-484-3333 Fax: 641-484-3208 |
Dr. Cindy Elaine Nielsen, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1646 305th St, Tama, IA 52339 Phone: 641-484-4094 |
News Archive
In recent years, many groups, including policy makers and health systems, have looked for ways to reduce the number of visits to the emergency department (ED) as a way to lower costs and improve the quality of care. Research conducted by Jesse Pines, M.D., director of the Office of Clinical Practice Innovation and professor of emergency medicine at the George Washington University (GW) School of Medicine and Health Sciences, explored interventions that had been implemented outside of EDs that were designed to reduce ED use.
The genetic fingerprint of a metastatic cancer is constantly changing, which means that the therapy that may have stopped a patient's cancer growth today, won't necessarily work tomorrow.
Cigarette smoking kills approximately 440,000 Americans each year, according to the Centers for Disease Control and Protection. It's the leading cause of preventable death worldwide. In order to overcome this addiction, many people resort to nicotine replacement therapies.
Women at high genetic risk of breast cancer could reduce their risk of developing the disease at an early age by taking oral contraceptives, a new study has found. The findings contradict previous studies, which suggested oral contraceptive use would increase the risk of developing breast cancer.
MediciNova, Inc, a biopharmaceutical company publicly traded on the Nasdaq Global Market and the Hercules Market of the Osaka Securities Exchange, today reported that this week's issue of Neurology includes two articles related to the potential clinical utility and unique pharmacological action of MN-166 in treating multiple sclerosis (MS).
› Verified 4 days ago